OM - NASDAQ

Outset Medical, Inc.

Outset Medical, Inc.

OM·NASDAQ

$4.60

-6.3%
HealthcareMedical - Devices

Outset Medical, Inc., a medical technology company, develops a hemodialysis system for dialysis. It provides the Tablo Hemodialysis System, which comprises a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities for dialysis care in acute and home settings. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.

StatementsValue Model

At a Glance

Live Snapshot
Market Cap$85.27M
EPS-5.3700
P/E Ratio-0.86
Earnings Date08/05/2026

Available Earnings Call Transcripts

Select a year and quarter to view the full transcript.

Outset Medical, Inc.

Outset Medical, Inc. Earnings Call Transcripts

OM · NASDAQ

Related Guides

Blog Categories

Continue your OM research with focused valuation guides.

Forecasting

Compare management guidance with modeled outcomes.

Risk Analysis

Track estimate risk, misses, and downside scenarios.

Reference

Review analyst process and transcript interpretation.

Value Investing

Anchor quarterly narrative to intrinsic value discipline.

Research Paths

Pick your next lens
1

Snapshot

Start with context, operating signals, and key market metrics.

2

Value Model

Stress test fair value across bear, base, and bull assumptions.

3

Statements

Validate revenue quality, margins, and balance sheet durability.

4

Earnings Call

Read management commentary and compare it with reported outcomes.

5

Dividends

Check payout sustainability and long-term distribution behavior.

6

Analyst Expectations

Review consensus spread and where estimate risk is concentrated.